JP2023517722A5 - - Google Patents

Info

Publication number
JP2023517722A5
JP2023517722A5 JP2022555805A JP2022555805A JP2023517722A5 JP 2023517722 A5 JP2023517722 A5 JP 2023517722A5 JP 2022555805 A JP2022555805 A JP 2022555805A JP 2022555805 A JP2022555805 A JP 2022555805A JP 2023517722 A5 JP2023517722 A5 JP 2023517722A5
Authority
JP
Japan
Application number
JP2022555805A
Other languages
Japanese (ja)
Other versions
JP7779846B2 (ja
JPWO2021185748A5 (https=
JP2023517722A (ja
Filing date
Publication date
Priority claimed from EP20382194.7A external-priority patent/EP3882240A1/en
Application filed filed Critical
Publication of JP2023517722A publication Critical patent/JP2023517722A/ja
Publication of JP2023517722A5 publication Critical patent/JP2023517722A5/ja
Publication of JPWO2021185748A5 publication Critical patent/JPWO2021185748A5/ja
Application granted granted Critical
Publication of JP7779846B2 publication Critical patent/JP7779846B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022555805A 2020-03-16 2021-03-15 (1r,3s)-3-(5-シアノ-4-フェニル-1,3-チアゾール-2-イルカルバモイル)シクロペンタンカルボン酸の共結晶 Active JP7779846B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20382194.7A EP3882240A1 (en) 2020-03-16 2020-03-16 Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid
EP20382194.7 2020-03-16
PCT/EP2021/056506 WO2021185748A1 (en) 2020-03-16 2021-03-15 Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid

Publications (4)

Publication Number Publication Date
JP2023517722A JP2023517722A (ja) 2023-04-26
JP2023517722A5 true JP2023517722A5 (https=) 2024-03-26
JPWO2021185748A5 JPWO2021185748A5 (https=) 2024-03-26
JP7779846B2 JP7779846B2 (ja) 2025-12-03

Family

ID=69953938

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022555805A Active JP7779846B2 (ja) 2020-03-16 2021-03-15 (1r,3s)-3-(5-シアノ-4-フェニル-1,3-チアゾール-2-イルカルバモイル)シクロペンタンカルボン酸の共結晶

Country Status (21)

Country Link
US (1) US12384754B2 (https=)
EP (2) EP3882240A1 (https=)
JP (1) JP7779846B2 (https=)
KR (1) KR20220154791A (https=)
CN (1) CN115298169B (https=)
AU (1) AU2021237686B2 (https=)
BR (1) BR112022018449A2 (https=)
CA (1) CA3171894C (https=)
DK (1) DK4121419T3 (https=)
ES (1) ES3002084T3 (https=)
FI (1) FI4121419T3 (https=)
HR (1) HRP20241515T1 (https=)
HU (1) HUE068886T2 (https=)
LT (1) LT4121419T (https=)
MX (1) MX2022011530A (https=)
PL (1) PL4121419T3 (https=)
PT (1) PT4121419T (https=)
RS (1) RS66214B1 (https=)
SI (1) SI4121419T1 (https=)
WO (1) WO2021185748A1 (https=)
ZA (1) ZA202211247B (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2331220B1 (es) 2007-10-02 2010-09-23 Palobiofarma, S.L. Nuevos compuestos como antagonistas de los receptores a1 de adenosina.
US8779146B2 (en) 2010-04-28 2014-07-15 Nuformix Limited Cilostazol cocrystals and compositions
LT3592734T (lt) 2017-03-06 2021-07-26 Palobiofarma, S.L. (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksirūgšties amino druska

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)